Synbiotic Combination of Lactococcus lactis LB1022 and Fructo-Oligosaccharides Mitigates the Atopic March by Modulating the Microbiota-Gut–Skin–Lung Axis
Journal of Microbiology and Biotechnology · 2026
DOI: 10.4014/jmb.2511.11044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2026. Verfasst von Jihye Baek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea. Hauptthemen laut MEDLINE: Synbiotics, Lactococcus lactis, Oligosaccharides, Dermatitis, Atopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of SMEs and Startups, Chung-Ang University.
Abstract (Originalsprache)
Dysregulated gut microbiota is increasingly recognized as a major contributor to allergic diseases and their progression.A key clinical manifestation of this progression is the atopic march, in which atopic dermatitis (AD) precedes the development of allergic airway disease.Although prebiotics and probiotics individually improve AD symptoms, their combined use as synbiotics, especially with regard to preventing the progression from cutaneous inflammation to airway hypersensitivity, has not been clearly established.In this study, we assessed the biological activity of a synbiotic composed of fructooligosaccharides (FOS) and Lactococcus lactis LB1022 in an ovalbumin (OVA)-induced murine model of AD and asthma-like inflammation.Female BALB/c mice were treated for eight weeks with FOS, L. lactis LB1022, or their combination following OVA sensitization.The synbiotic formulation produced the strongest protective effects, markedly reducing AD-like skin pathology, suppressing airway inflammatory cell influx, and lowering Th2skewed cytokine responses.These protective effects were further supported by significant reductions in serum IgE and Th2-associated IgG1 levels.Synbiotic treatment also enriched multiple short-chain fatty acid (SCFA)-producing taxa, including Lactobacillus and Bifidobacterium species, resulting in increased fecal SCFA concentrations that were closely associated with improvements in systemic and mucosal immunity.These results demonstrate that the FOS-L.lactis LB1022 synbiotic mitigates both epidermal and respiratory allergic inflammation through coordinated regulation of the microbiota-gutskin-lung axis.The findings highlight a promising dietary approach for reducing the risk of progression along the atopic march and address an important gap in current allergyrelated microbiome research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea.
- Faculty of Arts and Science, University of Toronto, Toronto, Ontario M5S 1A1, Canada.
- Department of Medical Science, Chung-Ang University Graduate School, Seoul 06974, Republic of Korea.
- LuxBiome Co., Ltd., Seoul 06974, Republic of Korea.
- Pathophysiology Laboratory, Chung-Ang University College of Pharmacy, Seoul 06974, Republic of Korea.
- Division of Pulmonology and Allergology, Department of Internal Medicine, Chung-Ang University College of Medicine and Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Förderung
- Ministry of SMEs and Startups
- Chung-Ang University
Zitieren
APA
Baek, J., Choi, D. H., Park, B. E., Cho, E., Kim, K., Lee, J. Y., Shin, J. W., & Kim, W. (2026). Synbiotic Combination of Lactococcus lactis LB1022 and Fructo-Oligosaccharides Mitigates the Atopic March by Modulating the Microbiota-Gut–Skin–Lung Axis. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2511.11044
Vancouver
Baek J, Choi DH, Park BE, Cho E, Kim K, Lee JY, et al. Synbiotic Combination of Lactococcus lactis LB1022 and Fructo-Oligosaccharides Mitigates the Atopic March by Modulating the Microbiota-Gut–Skin–Lung Axis. Journal of Microbiology and Biotechnology. 2026. doi:10.4014/jmb.2511.11044
BibTeX
@article{Baek2026,
author = {Baek, Jihye and Choi, David Hyung-Sun and Park, Byoung Eon and Cho, Eunseo and Kim, Kiyoung and Lee, Ji-Yun and Shin, Jong Wook and Kim, Wonyong},
title = {Synbiotic Combination of Lactococcus lactis LB1022 and Fructo-Oligosaccharides Mitigates the Atopic March by Modulating the Microbiota-Gut–Skin–Lung Axis},
journal = {Journal of Microbiology and Biotechnology},
year = {2026},
doi = {10.4014/jmb.2511.11044}
}
EUVIMED